Vitiligo cannot be cured, but treatments can stop it from spreading and restore color to affected skin

There is no cure for vitiligo. The condition is permanent, and the underlying cause—loss of pigment-producing cells called melanocytes—cannot be reversed once those cells are gone. However, this does not mean nothing can be done. Modern treatments can halt the progression of new patches, bring back color to existing patches in many people, and prevent the emotional and social burden from worsening. The goal of treatment is not to cure vitiligo but to manage it: stop new depigmentation and restore pigment where possible.

Whether treatment works depends on how long you have had vitiligo, where the patches are located, your skin tone, and which treatment you choose. Some people see significant repigmentation; others see modest improvement. A few see little change. Starting treatment early—before patches become very large or very old—generally gives better results than waiting.

Key Takeaways

  • Vitiligo has no cure, but treatments can stop new patches from forming and restore color to existing ones in many people.
  • Topical corticosteroids and calcineurin inhibitors are first-line treatments that work best on the face and trunk, less well on hands and feet.
  • Phototherapy (light-based treatment) and newer oral medications like JAK inhibitors show promise, especially when combined with topical treatments.
  • Surgical options such as skin grafting exist for stable vitiligo but require the disease to have stopped spreading for at least a year.
  • How much color returns depends on patch age, location, and individual response—some people regain significant pigment while others see minimal change.

Why vitiligo cannot be cured

Vitiligo occurs when melanocytes—the cells that produce melanin (the pigment that colors skin)—are destroyed or stop functioning. The exact reason this happens is not fully understood, but evidence points to a combination of genetic predisposition, immune system malfunction, and possibly environmental triggers. The immune system appears to attack melanocytes as if they were foreign invaders.

Once melanocytes in a patch are lost, they do not naturally regenerate. The body does not have a mechanism to replace them. This is why vitiligo is permanent and why no treatment can truly "cure" it in the sense of restoring the original cells. Instead, treatments work by either protecting remaining melanocytes from further attack or stimulating melanocytes at the edges of patches to multiply and spread inward, gradually covering the depigmented area again.

Topical treatments: the first step

Topical corticosteroids are usually the first treatment doctors recommend. These are creams or ointments containing steroid hormones that reduce inflammation and suppress the immune response in the skin. They work best on patches on the face, neck, and upper trunk—areas with thinner skin and better blood flow. On hands, feet, and other areas with thicker skin, they are less effective. Potency varies; stronger steroids work faster but carry a higher risk of skin thinning with long-term use.

Calcineurin inhibitors (tacrolimus and pimecrolimus) are non-steroid creams that also suppress local immune activity. They do not cause skin thinning, making them safer for long-term use and for sensitive areas like the face. They work more slowly than strong steroids but can be used indefinitely. Many dermatologists recommend combining a topical steroid with a calcineurin inhibitor for better results.

Topical treatments typically take 3 to 6 months to show visible repigmentation, and results plateau after that. If a patch does not respond within 6 months, switching to a different topical or adding a systemic treatment usually makes sense.

Phototherapy and light-based treatments

Narrowband ultraviolet B (NB-UVB) phototherapy is a light-based treatment where you stand in a special cabinet and expose your whole body to controlled UVB light, typically twice per week. It works by suppressing the immune attack on melanocytes and stimulating them to produce pigment. Studies show that 75% of people using NB-UVB see at least some repigmentation, and about 25% achieve near-complete clearing of patches.

NB-UVB requires a commitment: treatment usually lasts 3 to 6 months or longer, with visits to a clinic twice weekly. It works best when combined with topical treatments. The main drawback is access—not all areas have phototherapy clinics, and insurance coverage varies.

Excimer laser is a targeted form of phototherapy that delivers UVB light to specific patches rather than the whole body. It is useful for small, localized patches and can be done in an office setting. Results are similar to NB-UVB but require fewer visits.

Oral and systemic medications

JAK inhibitors are a newer class of oral medication that blocks Janus kinase enzymes, which play a role in immune cell signaling. Ruxolitinib (Opzelura) is a topical JAK inhibitor approved by the FDA for vitiligo, and oral JAK inhibitors are being studied in clinical trials. Early evidence suggests they can halt progression and restore color, particularly when combined with phototherapy. These medications are expensive and require monitoring, but they represent a meaningful advance for people who do not respond to topical treatments alone.

Oral corticosteroids (such as prednisone) can slow the spread of vitiligo, especially in people with rapidly progressing disease. However, they carry risks with long-term use—bone loss, infection risk, weight gain—so they are typically used short-term or at low doses to stabilize the disease before moving to topical or light-based treatments.

Surgical options for stable vitiligo

Surgery is only considered after vitiligo has been stable for at least 12 months—meaning no new patches have appeared and existing patches have not grown. The most common surgical approach is autologous skin grafting, where healthy pigmented skin from one part of your body is transplanted to depigmented patches. Success rates are high (80% to 90% repigmentation in grafted areas), but the procedure is invasive, leaves scars at both the donor and recipient sites, and works best on small, localized patches.

Other surgical options include melanocyte transplantation (harvesting melanocytes from healthy skin and transplanting them to patches) and punch grafting (transferring small dots of healthy skin). These are more specialized and available only at certain centers.

Factors that affect how well treatment works

Not everyone responds equally to the same treatment. Several factors influence outcomes. Patch age matters: newer patches respond better than patches that have been present for years. Location is critical—patches on the face and trunk respond much better than those on hands, feet, and lips. Skin tone affects visibility: depigmented patches are more noticeable on darker skin, but repigmentation is also easier to see. Disease activity (whether new patches are still appearing) influences which treatments work best; rapidly progressive vitiligo may need systemic treatment first.

Individual variation is substantial. Two people with similar patches may have very different responses to the same treatment. This is why dermatologists often recommend starting with topical treatments, assessing response after 3 to 6 months, and adjusting the plan based on what actually happens rather than what is predicted.

Living with vitiligo while in treatment

While waiting for treatment to work, or if treatment provides only partial repigmentation, cosmetic camouflage can help. Specialized cover-up products designed for vitiligo are waterproof and long-lasting. Sunscreen is essential on depigmented patches, which have no melanin and burn easily. Some people use self-tanning products or temporary dyes to even out skin tone.

The psychological impact of vitiligo is real. Patches on visible areas like the face and hands can affect self-image and social confidence. Counseling or support groups can help, and many dermatologists now screen for depression and anxiety in vitiligo patients as part of routine care.

Frequently Asked Questions

Can vitiligo go away on its own?

Vitiligo does not go away without treatment. In rare cases, patches may stop spreading and remain stable, but depigmented areas do not spontaneously regain color. Early treatment offers the best chance of halting progression and restoring pigment.

How long does it take to see results from treatment?

Topical treatments typically show visible results within 3 to 6 months. Phototherapy may take 2 to 3 months of twice-weekly sessions. JAK inhibitors and oral medications can show effects within weeks to months. Patience is necessary—vitiligo treatment is slow.

What happens if treatment stops working?

If a treatment plateaus or stops working, dermatologists usually switch to a different approach or combine treatments. For example, adding phototherapy to topical steroids often improves results when either alone is insufficient. Treatment plans are adjusted based on response.

Is vitiligo hereditary, and does that affect treatment?

Vitiligo does run in families, but having a family history does not change how treatment works. Genetic predisposition affects whether you develop vitiligo, not how well you respond to therapy. Treatment recommendations are based on disease characteristics, not family history.

Can stress or diet cure vitiligo?

Stress and diet do not cause vitiligo and cannot cure it. However, some evidence suggests that managing stress and maintaining good nutrition may support overall skin health and potentially slow progression. These are helpful habits but not substitutes for medical treatment.